Tocilizumab in ICU-admitted COVID-19 Patients: A Retrospective Study.
Zeinab SiamiMojtaba Hedayat YaghoobiParsa KarimiPublished in: Medical journal of the Islamic Republic of Iran (2023)
The use of TCZ in ICU-hospitalized patients resulted in improved patient survival and reduced duration of hospitalization. Further studies are needed to confirm the efficacy of TCZ in severe and critical COVID-19 cases.
Keyphrases
- sars cov
- intensive care unit
- mechanical ventilation
- coronavirus disease
- rheumatoid arthritis
- case report
- early onset
- respiratory syndrome coronavirus
- rheumatoid arthritis patients
- juvenile idiopathic arthritis
- free survival
- acute respiratory distress syndrome
- drug induced
- systemic lupus erythematosus
- disease activity